Covariates | Model 1 | Model 2 | ||||||
---|---|---|---|---|---|---|---|---|
Unadjusted models | Adjusted AIC-reduced modelb | Unadjusted models | Adjusted AIC-reduced modelc | |||||
Regr.coeff. (SE) | p-value | Regr.coeff. (SE) | p-value | Regr.coeff. (SE) | p-value | Regr.coeff. (SE) | p-value | |
Main variables | ||||||||
 Time | 0.0006 (0.0006) | 0.244 | 0.0007 (0.0005) | 0.191 | −0.0002 (0.0005) | 0.690 | −0.0003 (0.0004) | 0.530 |
 CDR-SoB | 0.03 (0.002) | < 0.001 | 0.01 (0.003) | < 0.001 | 0.03 (0.002) | < 0.001 | 0.01 (0.002) | < 0.001 |
 CDR-SoB*Time | −0.0005 (0.0001) | < 0.001 | −0.0005 (0.0001) | < 0.001 | − 0.0005 (0.00009) | < 0.001 | −0.0003 (0.00008) | < 0.001 |
Socio-demographic information | ||||||||
 Women | 0.04 (0.01) | 0.006 | 0.03 (0.01) | 0.027 | 0.04 (0.01) | 0.002 | 0.03 (0.01) | 0.009 |
 Age (years) | −0.004 (0.001) | < 0.001 | −0.004 (0.001) | 0.001 | −0.005 (0.001) | < 0.001 | − 0.002 (0.0009) | 0.026 |
 Single | 0.009 (0.01) | 0.515 |  |  | 0.01 (0.01) | 0.330 |  |  |
General physical health | ||||||||
 GMHR | ||||||||
  Very poor | 0.08 (0.03) | 0.003 |  |  | 0.08 (0.03) | 0.002 | 0.07 (0.02) | 0.001 |
  Poor | 0.02 (0.02) | 0.393 |  |  | 0.04 (0.02) | 0.067 | 0.03 (0.02) | 0.054 |
  Fair | 0.008 (0.02) | 0.635 |  |  | 0.0008 (0.02) | 0.968 | 0.004 (0.02) | 0.813 |
  Good – ref. | 0 |  |  |  |  |  |  |  |
P-ADL | 0.0006 (0.002) | 0.791 |  |  | −0.001 (0.002) | 0.577 |  |  |
I-ADL | −0.003 (0.004) | 0.501 | −0.008 (0.004) | 0.047 | 0.0005 (0.004) | 0.899 |  |  |
Neuropsychiatric sub-syndrome score | ||||||||
 Agitation | 0.02 (0.001) | < 0.001 | 0.008 (0.001) | < 0.001 | 0.02 (0.001) | < 0.001 | 0.01 (0.001) | < 0.001 |
 Psychosis | 0.02 (0.003) | < 0.001 |  |  | 0.02 (0.003) | < 0.001 |  |  |
 Affective | 0.02 (0.001) | < 0.001 | 0.02 (0.001) | < 0.001 | 0.03 (0.001) | < 0.001 | 0.02 (0.001) | < 0.001 |
Use of psychotropic medication | ||||||||
 Antipsychotics | 0.004 (0.03) | 0.891 |  |  | −0.02 (0.03) | 0.476 |  |  |
 Antidepressants | 0.03 (0.02) | 0.086 |  |  | 0.04 (0.02) | 0.032 |  |  |
 Anxiolytics | 0.009 (0.02) | 0.674 |  |  | 0.03 (0.02) | 0.113 |  |  |
 Sedatives | 0.03 (0.01) | 0.024 | 0.03 (0.01) | 0.030 | 0.04 (0.01) | 0.006 |  |  |
 Cognitive enhancers | 0.05 (0.03) | 0.079 |  |  | 0.01 (0.03) | 0.588 |  |  |
NH resident beforeT3 |  |  |  |  | −0.12 (0.03) | < 0.001 | −0.07 (0.02) | 0.001 |